134 related articles for article (PubMed ID: 8628145)
21. Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniae.
Karlowsky JA; Jones ME
J Antimicrob Chemother; 2003 Feb; 51(2):467-8. PubMed ID: 12562727
[No Abstract] [Full Text] [Related]
22. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.
Friedland IR; Shelton S; McCracken GH
J Clin Microbiol; 1993 Jun; 31(6):1619-21. PubMed ID: 8315005
[TBL] [Abstract][Full Text] [Related]
23. [Current status of pneumococcal resistance].
Roussel-Delvallez M
Presse Med; 1998 Sep; 27 Suppl 4():9-10. PubMed ID: 9798475
[No Abstract] [Full Text] [Related]
24. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
25. In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis.
Fernández-Roblas R; López JC; Ramos JM; Gimeno M; Coronel P; Soriano F
J Antimicrob Chemother; 1996 May; 37(5):1038-9. PubMed ID: 8737159
[No Abstract] [Full Text] [Related]
26. Evolution of extended spectrum cephalosporin resistance in the pneumococcus.
Koornhof HJ; Klugman KP
J Antimicrob Chemother; 1997 Jun; 39(6):837-8. PubMed ID: 9222059
[No Abstract] [Full Text] [Related]
27. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Nomura S; Hanaki H; Furukawa T; Unemi N
Chemotherapy; 1997; 43(1):1-5. PubMed ID: 8996734
[TBL] [Abstract][Full Text] [Related]
29. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
Glatz K; Szabó D; Szabó G; Boriszova D; Rozgonyi F
J Antimicrob Chemother; 2001 Nov; 48(5):731-4. PubMed ID: 11679565
[TBL] [Abstract][Full Text] [Related]
30. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics.
Bosley GS; Elliott JA; Oxtoby MJ; Facklam RR
Diagn Microbiol Infect Dis; 1987 May; 7(1):21-7. PubMed ID: 3691031
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.
Doern GV; Diekema DJ; Heilmann KP; Dohrn CL; Riahi F; Richter SS
Antimicrob Agents Chemother; 2012 Jun; 56(6):3406-8. PubMed ID: 22491687
[TBL] [Abstract][Full Text] [Related]
33. [Antibiotic resistance: an always present problem].
Debbia EA
Recenti Prog Med; 1999 Oct; 90(10):505-9. PubMed ID: 10592734
[No Abstract] [Full Text] [Related]
34. Isolation in France of a clinical strain of Streptoccus pneumoniae susceptible to amoxycillin and resistant to cefotaxime.
Vergnaud M; Prévost JN; Malbruny B; Brun J; Leclercq R
Clin Microbiol Infect; 2000 May; 6(5):283-4. PubMed ID: 11168130
[No Abstract] [Full Text] [Related]
35. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
Lin E; Stanek RJ; Mufson MA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1151-3. PubMed ID: 12604560
[TBL] [Abstract][Full Text] [Related]
36. Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae.
Smith AM; Klugman KP
Microb Drug Resist; 2000; 6(2):105-10. PubMed ID: 10990264
[TBL] [Abstract][Full Text] [Related]
37. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
McCracken GH; Sakata Y
Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic sensitivity pattern of pneumococci relatively insensitive to penicillin and cephalosporin antibiotics.
Hansman D
Med J Aust; 1975 Nov; 2(19):740-2. PubMed ID: 2851
[TBL] [Abstract][Full Text] [Related]
40. Decreased susceptibility to extended-spectrum cephalosporins of a penicillin-susceptible Streptococcus pneumoniae in meningitis.
De Champs C; Constantin JM; Bonnet R; Guelon D; Goldstein F; Sirot J
Infection; 2000; 28(1):58-9. PubMed ID: 10697797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
